CClinicalTrials.gg
CompletedNCT01867515Updated Apr 26, 2018Results posted

Spectral Dynamics and Speech Understanding by Hearing Impaired People

An interventional study of Acoustic distortion of speech in Hearing Loss, Sensorineural, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-26.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this program of research is to understand the perception of the dynamic spectral properties of speech by hearing-impaired listeners, with the long-term goal of improving speech understanding by these individuals in adverse listening conditions. The proposed research compares the performance of normally-hearing and hearing-impaired listeners on measures of speech understanding in the presence of different types of signal distortion and speech understanding of signals with enhanced spectral dynamics. A computational model based on the amount of potential information available in speech will be used to quantify differences in speech intelligibility due to hearing status and stimulus characteristics.

Read the detailed description

This is a behavioral study of human auditory perception. Each experiment in this study involves prospective data collection from three types of listeners. The experimental listeners will be people with sensorineural hearing loss and the control listeners will either be subjects with normal hearing or normal-hearing listeners for whom hearing loss will be simulated through the use of a spectrally-shaped broadband noise. The tasks of the subjects in this study involve either listening to synthesized sounds over earphones while seated comfortably in a sound-treated booth, and making responses indicating the subject's auditory perception of these sounds by touching specific areas on a touch-screen terminal; or, listening to recorded, acoustically modified syllables, words, or sentences over earphones and making responses indicating the subject's identification.

02

Conditions studied

  • Hearing Loss, Sensorineural

Keywords

  • Hearing
  • Hearing Loss, sensorineural
  • Speech Perception
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 50 is above the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • individuals with hearing thresholds of 20 dB HL or better at all octave frequencies between 250 Hz and 4000 Hz
  • or, individuals with bilateral sensorineural hearing losses with thresholds between 25 and 70 dB HL and no losses greater than 70 dB HL at frequencies of 4000 Hz or below

Exclusion criteria

Exclusion Criteria:

  • a conductive hearing impairment or other otological pathology
  • hearing thresholds greater than 70 dB HL at any frequencies of 4000 Hz or below or pure-tone averages (averaged across 500, 1000, and 2000 Hz) of greater than 65 dB HL
  • bilateral differences greater than 20 dB at any frequency below 4000 Hz
  • an inability to complete the experimental tasks
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Younger normally-hearing listeners

    Participants with auditory thresholds within the normal limits. * age between 18 and 35 * individuals with hearing thresholds of 20 dB HL or better at all octave frequencies between 250 Hz and 4000 Hz Acoustic distortion of speech

    Other: Acoustic distortion of speech

  • Active comparator
    Hearing-impaired listeners

    individuals with bilateral sensorineural hearing losses with thresholds between 25 and 70 dB HL and no losses greater than 70 dB HL at frequencies of 4000 Hz or below * age 18 to 65 Acoustic distortion of speech

    Other: Acoustic distortion of speech

  • Active comparator
    Older normally-hearing listeners

    Participants with auditory thresholds within the normal limits. * age between 36 and 65 * individuals with hearing thresholds of 20 dB HL or better at all octave frequencies between 250 Hz and 4000 Hz Acoustic distortion of speech

    Other: Acoustic distortion of speech

Interventions

  • OtherAcoustic distortion of speech
06

What researchers measure

Primary outcomes

  1. Percent Correct Words Identified

    The experimental approach compares speech identification performance among younger, normally-hearing listeners, older normally-hearing listeners and hearing-impaired listeners. Tasks will be carried out in quiet and in the presence of continuous, speech-shaped background noise. The investigators compared the understanding of unprocessed stimuli with 1) time-compressed stimuli, 2) time-compressed stimuli expanded in time via gaps and 3) uncompressed stimuli where portions of the signal were replaced with silence. Experimental metrics were percentage of correct/incorrect speech identification in each listening condition.

    Time frame: average of two blocks per condition obtained over the course of up to three 2-hour visits, spaced an average of one week apart

07

Results

Posted Apr 26, 2018

Participant flow

Participant flow — Overall Study
MilestoneYounger Normally-hearing ListenersOlder Normally-hearing ListenersHearing-impaired Listeners
Started131225
Completed131114
Not completed0111

Outcome measures

PrimaryPercent Correct Words Identified

The experimental approach compares speech identification performance among younger, normally-hearing listeners, older normally-hearing listeners and hearing-impaired listeners. Tasks will be carried out in quiet and in the presence of continuous, speech-shaped background noise. The investigators compared the understanding of unprocessed stimuli with 1) time-compressed stimuli, 2) time-compressed stimuli expanded in time via gaps and 3) uncompressed stimuli where portions of the signal were replaced with silence. Experimental metrics were percentage of correct/incorrect speech identification in each listening condition.

Time frame:
average of two blocks per condition obtained over the course of up to three 2-hour visits, spaced an average of one week apart
Reported as:
Mean · percentage of words identified
Percent Correct Words Identified
percentage of words identifiedNormally-hearing ListenersOlder Normally-hearingHearing-impaired Listeners
Unprocessed speech in quiet98.6 (88 to 100)97.1 (84 to 100)91.9 (64 to 100)
Unprocessed speech in noise98.8 (88 to 100)96.2 (72 to 100)91.3 (68 to 100)
Time-compressed (50%) speech in quiet95.7 (60 to 100)96.4 (84 to 100)86.4 (24 to 100)
Time-compressed (50%) speech in noise89.5 (72 to 100)80.2 (60 to 96)57.9 (8 to 92)
Time-compressed (66%) speech in quiet92.8 (60 to 100)86.4 (52 to 100)66.9 (24 to 100)
Time-compressed (66%) speech in noise47.7 (8 to 80)26.2 (4 to 60)11.3 (0 to 44)
Time-compressed (80%) speech in quiet39.8 (8 to 88)12.2 (0 to 60)7.1 (0 to 64)
Time-compressed (80%) speech in noise1.4 (0 to 8)0.7 (0 to 4)0.3 (0 to 4)
Interrupted (50%) speech in quiet98.5 (88 to 100)96.2 (80 to 100)85.6 (56 to 100)
Interrupted (50%) speech in noise89.7 (68 to 100)84.7 (64 to 100)58.7 (20 to 92)
Interrupted (66%) speech in quiet98.3 (88 to 100)94.9 (80 to 100)73.3 (24 to 100)
Interrupted (66%) speech in noise69.8 (40 to 84)60.7 (24 to 84)36.6 (8 to 84)
Interrupted (80%) speech in quiet86.3 (60 to 100)70.7 (8 to 92)46.1 (4 to 96)
Interrupted (80%) speech in noise47.1 (20 to 84)38.9 (4 to 60)19.7 (0 to 64)
Time-compressed/Expanded (50%) speech in quiet98.5 (84 to 100)96.7 (88 to 100)86.3 (36 to 100)
Time-compressed/Expanded (50%) speech in noise93.4 (84 to 100)86.9 (56 to 100)69.1 (32 to 100)
Time-compressed/Expanded (66%) speech in quiet98 (72 to 100)95.6 (80 to 100)77.4 (40 to 100)
Time-compressed/Expanded (66%) speech in noise83.7 (40 to 100)72.7 (24 to 92)50.7 (10 to 96)
Time-compressed/Expanded (80%) speech in quiet93.7 (64 to 100)89.5 (56 to 100)66 (24 to 100)
Time-compressed/Expanded (80%) speech in noise75.7 (40 to 100)57.6 (32 to 76)30 (4 to 76)

Adverse events

Collected over over the course of up to three 2-hour visits, spaced an average of one week apart. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Younger Normally-hearing Listeners0/13 (0%)0/13 (0%)0/13 (0%)
Older Normally-hearing Listeners0/11 (0%)0/11 (0%)0/11 (0%)
Hearing-impaired Listeners0/14 (0%)0/14 (0%)0/14 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Younger Normally-hearing ListenersOlder Normally-hearing ListenersHearing-impaired ListenersTotal
<=18 years0000
Between 18 and 65 years13101336
>=65 years0112
Age, Continuous
Age, Continuous(years)Younger Normally-hearing ListenersOlder Normally-hearing ListenersHearing-impaired ListenersTotal
Mean26.5 (20 to 33)59.1 (51 to 65)59.4 (48 to 65)48.0 (20 to 65)
Sex: Female, Male
Sex: Female, Male(Participants)Younger Normally-hearing ListenersOlder Normally-hearing ListenersHearing-impaired ListenersTotal
Female65213
Male761225
Region of Enrollment
Region of Enrollment(Participants)Younger Normally-hearing ListenersOlder Normally-hearing ListenersHearing-impaired ListenersTotal
United States13111438
08

Study locations

1 site
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon 97239, United States
09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01867515
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Jun 4, 2013
Start date
Aug 2013
Primary completion
Sep 2016
Completion
Sep 2016
Results posted
Apr 26, 2018
Last update
Apr 26, 2018

Study contacts

Michelle R Molis, PhD
principal investigator · VA Portland Health Care System, Portland, OR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion